Gene Editing of Embryos Gives Insight Into Basic Human Biology
By Marissa Fessenden,
Smithsonian.com [cites CGS' Marcy Darnovsky]
| 09. 21. 2017
A genetic tool allows researchers to disable a gene key to human development in a closely regulated experiment
For the first time, scientists edited a gene in fertilized human eggs critical to early development. The experiments helped the researchers learn about fundamental human biology in a way they could not through research on mice.
Researchers led by Kathy Niakan, a developmental biologist at the Francis Crick Institute in London, disabled a gene that codes for a protein called OCT4, known to be active in stem cells that can develop into all the cell types found in the body, reports Gretchen Vogel for Science. Turning the gene off ensured that cells from fertilized human eggs failed to form placental cells, yolk sac cells or even cells that would typically become a fetus.
Disabling the same gene in mouse embryos gives different results: Those embryos became balls of mostly placental cells. The findings suggest that the gene controls the fate of several cell lineages and plays a slightly different role in humans than in mice.
"This is opening up the possibility...
Related Articles
By Rhys Blakely, The Times | 06.24.2025
Scientists have created fertile mice from male genetic material alone, a breakthrough that could one day open the door to human babies who inherit their genes from two fathers.
The experiment, led by Professor Yanchang Wei at Shanghai Jiao Tong...
By Angus Liu, Fierce Pharma | 06.16.2025
A second patient has died following treatment with Sarepta Therapeutics’ Elevidys, raising more doubts about the Duchenne muscular dystrophy (DMD) gene therapy’s safety profile.
Sarepta and its ex-U.S. partner Roche reported the death early Sunday. Like the first case, disclosed...
By Sophie Alexander and Ike Swetlitz, Bloomberg | 06.25.2025
A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to one of the most controversial technologies in medicine.
Bootstrap Bio...
By Briana Contreras, Managed Healthcare Executive | 06.17.2025